Skip to content

Staying free of hepatitis C

To your health!

START… and why the time is now

What happens to people who become HIV positive in prevention trials?

Microbicides: the quest for user-friendly formulations

Treatment and PrEP could be on a ‘collision course’, warns resistance expert

New WHO treatment criteria could prevent 90% of vertical transmission

Fat loss caused by some anti-HIV drugs persists in the long term

Collaborative TB and HIV services for drug users